According to CapBio's announcement, as of August 31, 2026, the company had repurchased a total of 21.5736 million shares, accounting for 3.34% of the company's total share capital; the highest transaction price was 6.32 yuan/share, the lowest transaction price was 5.35 yuan/share, and the total amount of capital paid was 125 million yuan. This repurchase complies with laws and regulations and the company's repurchase plan, and the company will continue to implement the repurchase plan during the repurchase period.

According to CapBio's announcement, as of August 31, 2026, the company had repurchased a total of 21.5736 million shares, accounting for 3.34% of the company's total share capital; the highest transaction price was 6.32 yuan/share, the lowest transaction price was 5.35 yuan/share, and the total amount of capital paid was 125 million yuan. This repurchase complies with laws and regulations and the company's repurchase plan, and the company will continue to implement the repurchase plan during the repurchase period.